Date Range
toReport Types
Condition
See all (6)
Region of the Body
See all (5)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Slight improvement in response with temozolamide plus radiotherapy vs radiotherapy alone for STS
JPMA. The Journal of the Pakistan Medical Association. 2020 April 1;():. 10.5455/JPMA.293442
Zoledronate reduces radiation-induced bone collagen degradation in radiation therapy
Clin Transl Oncol. 2015 Jun;17(6):454-61.
Prostate cancer: Zoledronic acid as an adjuvant therapy is well-tolerated and improves BMD
Prostate Cancer Prostatic Dis. 2013 Dec;16(4):382-6. doi: 10.1038/pcan.2013.35. Epub 2013 Oct 1
Resistance & impact training has effect on lumbar bone mass and bone degradation markers
Breast Cancer Res Treat. 2011 Jun;127(2):447-56. doi: 10.1007/s10549-011-1444-z. Epub 2011 Mar 19
Ewing sarcoma: Similar survival rates with intensified dose regimen of VDC/IE
J Clin Oncol. 2009 May 20;27(15):2536-41. doi: 10.1200/JCO.2008.19.1478. Epub 2009 Apr 6
Ewing sarcoma treatment: assessment of cyclophosphamide and etoposide on survival rates
J Clin Oncol. 2008 Sep 20;26(27):4385-93. doi: 10.1200/JCO.2008.16.5720
Pulsed radiofrequency effective treatment option for degenerative spondylolisthesis
Eur Spine J. 2014 Sep;23(9):1927-32
Oral ibandronic acid inferior to IV zoledronic acid for metastatic breast cancer to bone
Lancet Oncol. 2014 Jan;15(1):114-22. doi: 10.1016/S1470-2045(13)70539-4.
Unstable distal radius fractures: Internal vs. external fixation complications and outcome
Int Orthop. 2011 Sep;35(9):1333-41. doi: 10.1007/s00264-011-1300-0. Epub 2011 Jun 23
Zoledronic acid reduces number of skeletal-related events in new multiple myeloma patients
Lancet Oncol. 2011 Aug;12(8):743-52. doi: 10.1016/S1470-2045(11)70157-7. Epub 2011 Jul 21